Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Pemphigus
- Types of pemphigus
- Pemphigus vulgaris: incidence
- Pemphigus pathogenesis (1)
- Schematic of keratinocyte desmosome
- Pemphigus pathogenesis (2)
- Clinical features
- Example: mucosal erosions in pemphigus vulgaris
- Difficulty in diagnosis of PV
- Pemphigus vulgaris oral lesions
- Cutaneous PV
- Pemphigus: diagnosis
- Direct Immunofluorescence (DIF) findings
- PV: histopathology and DIF
- Indirect immunofluorescence (IIF) and ELISA
- Treatment strategy
- Treatment of pemphigus vulgaris
- Prognosis of PV
- Paraneoplastic pemphigus
- Paraneoplastic pemphigus - DIF
- Thank you!
Topics Covered
- Epidemiology
- Oral and skin clinical features
- Pathogenesis
- Diagnosis
- Role of direct and indirect immunofluorescence
- Therapeutic strategy
- Paraneoplastic pemphigus
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Ficarra, G. (2017, March 29). Potentially lethal mouth diseases: pemphigus [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/WVFM8095.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Giuseppe Ficarra has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Potentially lethal mouth diseases: pemphigus
Published on March 29, 2017
11 min
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Dr. Giuseppe Ficarra.
I'm the Director of the Reference Center
for the Study of Oral Diseases in Florence.
And this is the second part,
we'll discuss pemphigus vulgaris
which is another fearsome disease.
0:17
Pemphigus represents
a group of blistering diseases
of skin and mucosal membrane.
There are several entities
included in the group.
Pathogenesis relates
to the action of autoantibodies
directed against transmembrane
adhesion molecules
which are constituents
of the keratinocytes desmosome.
These molecules are called desmogleins,
their destruction causes
epithelial disruption.
0:51
There are several types of pemphigus.
The most common entity is pemphigus vulgaris,
which although a rare disease
can involve the skin and the oral cavity.
Pemphigus foliaceus involves
only the skin
and typically seen in an endemic form
in certain geographic area
such as such South America,
for example, Brazil.
It includes several subtypes.
Paraneoplastic pemphigus
associated with a neoplastic disease
usually non Hodgkin lymphoma,
it will be discussed in more detail
later on.
1:32
The pemphigus vulgaris
is a quite rare disease,
and overall, its incidence
is between 0.076 cases to 5 cases
per 100,000 persons per year.
Likely then from this data
you can see that this is a very rare disease.
It shows preference for women.